ENTITY

Symbio Pharmaceuticals (4582 JP)

34
Analysis
Health CareJapan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
21 Jun 2021 17:43

Asia Shorts: Geely, Ganfeng, Pharmaron, Evergrande, Fujitsu, Canon, Renesas, Toshiba, LGD, Doosan

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
204 Views
Share
16 Jun 2020 06:33

🇯🇵 JAPAN - Stress Tests Part 2 - Operating Cash Flow & Accruals

STRESS TESTS - This Insight is the second in our Japan Stress Test series in which we endeavour to assess where business risk is concentrated...

Logo
337 Views
Share
28 Dec 2018 17:53

Japan Pharma - Top Picks (28 Dec 2018)

                                                                                                                                                   ...

18 Dec 2018 14:43

Japan Pharma - Top Picks

While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP)  is a contrarian call in anticipation of value...

21 Oct 2018 20:07

Japan Fortnightly Update: Spiked

SHORT-LIVED - The much-lauded 'breakout' in the Nikkei 225 (NKY INDEX) at the end of last month proved to be short-lived. As measured by Total...

Logo
359 Views
Share
x